Faculty Opinions recommendation of Suppression of serum luteinizing hormone in postmenopausal women by an orally administered nonpeptide antagonist of the gonadotropin-releasing hormone receptor (NBI-42902).
2006 ◽
Vol 91
(10)
◽
pp. 3903-3907
◽
2007 ◽
Vol 62
(3)
◽
pp. 187-189
2020 ◽
Vol 63
(20)
◽
pp. 11854-11881
◽
2009 ◽
Vol 81
(1)
◽
pp. 40-45
◽
2004 ◽
Vol 89
(9)
◽
pp. 4474-4479
◽
2005 ◽
Vol 84
(5)
◽
pp. 1529-1532
◽